Superales, Esterlita C.
HRN: 22-36-69 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2025
AZITHROMYCIN 500MG TABLET (TAB)
10/22/2025
10/27/2025
PO
500mg
OD
CAP MR
Waiting Final Action
10/22/2025
CEFTAZIDIME 1GM (VIAL)
10/22/2025
10/29/2025
IV
1gm
Q8
CAP MR
Waiting Final Action